These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31647346)

  • 1. Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
    Palaia I; Di Donato V; Musella A; Di Pinto A; Santangelo G; Petriglia G; Benedetti Panici P
    J Invest Surg; 2021 Jun; 34(6):672-676. PubMed ID: 31647346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
    Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
    Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
    Bese T; Sal V; Demirkiran F; Kahramanoglu I; Tokgozoglu N; Ilvan S; Aydin O; Hallac M; Vatankulu B; Demirayak G; Turan H; Arvas M
    Int J Gynecol Cancer; 2016 Sep; 26(7):1228-38. PubMed ID: 27643647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
    De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
    Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
    Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
    Wagner LM; Kremer N; Gelfand MJ; Sharp SE; Turpin BK; Nagarajan R; Tiao GM; Pressey JG; Yin J; Dasgupta R
    Cancer; 2017 Jan; 123(1):155-160. PubMed ID: 27563842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node Staging with a Combined Protocol of
    Weissinger M; Taran FA; Gatidis S; Kommoss S; Nikolaou K; Sahbai S; Fougère C; Brucker SY; Dittmann H
    J Nucl Med; 2021 Aug; 62(8):1062-1067. PubMed ID: 33509973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
    Pritchard KI; Julian JA; Holloway CM; McCready D; Gulenchyn KY; George R; Hodgson N; Lovrics P; Perera F; Elavathil L; O'Malley FP; Down N; Bodurtha A; Shelley W; Levine MN
    J Clin Oncol; 2012 Apr; 30(12):1274-9. PubMed ID: 22393089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model.
    Anderson KM; Barback CV; Qin Z; Hall DJ; Hoh CK; Vera DR; McHale MT
    PLoS One; 2018; 13(7):e0197842. PubMed ID: 29965996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
    Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
    Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
    Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.